Literature DB >> 22868540

Acute and preventive treatment of migraine.

Paul B Rizzoli1.   

Abstract

PURPOSE OF REVIEW: Migraine remains underdiagnosed and undertreated despite advances in the understanding of its pathophysiology and management. This article focuses on acute and preventive treatment of migraine, including the mechanisms of action, dosing and side effects of medications, and strategies for the most effective care. RECENT
FINDINGS: Best practice suggests that acute migraine treatment should be stratified based on the severity of the individual event, with a goal of returning the patient to full function within 2 hours of treatment. Migraine prevention strategies continue to be underused in the United States. More than 1 in 4 patients with migraines may be candidates for preventive therapy. To obtain the best results from preventive therapy, slow titration to an adequate dose for an adequate timeframe with good documentation of the results is recommended.
SUMMARY: This article reviews several options for managing acute attacks, including information on expected efficacy, dosing, and adverse effects. Strategies for effective application of acute therapies are discussed. Prevention can be added to acute therapy depending on headache characteristics such as frequency, severity, disability, and the presence of comorbid conditions. The mechanisms of action of preventive medications and strategies for their most effective use are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868540     DOI: 10.1212/01.CON.0000418641.45522.3b

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  14 in total

Review 1.  Headache and Its Management in Patients With Multiple Sclerosis.

Authors:  Farhat Husain; Gabriel Pardo; Meheroz Rabadi
Journal:  Curr Treat Options Neurol       Date:  2018-03-24       Impact factor: 3.598

Review 2.  Acute Treatment of Migraine.

Authors:  Vesile Öztürk
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

3.  Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.

Authors:  Chao Liu; Liang Fang
Journal:  AAPS PharmSciTech       Date:  2015-03-14       Impact factor: 3.246

4.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

Review 5.  A new era in headache treatment.

Authors:  Michail Vikelis; Konstantinos C Spingos; Alan M Rapoport
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

6.  Sleep-related headache and its management.

Authors:  Niranjan N Singh; Pradeep Sahota
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

7.  Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine.

Authors:  Kobina K Hagan; Wenyuan Li; Elizabeth Mostofsky; Suzanne M Bertisch; Angeliki Vgontzas; Catherine Buettner; Murray A Mittleman
Journal:  Headache       Date:  2020-12-21       Impact factor: 5.887

8.  Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs.

Authors:  Anthony D Andre; Elimor Brand-Schieber; Margarita Ramirez; Sagar Munjal; Rajesh Kumar
Journal:  Patient Prefer Adherence       Date:  2017-01-19       Impact factor: 2.711

Review 9.  Triptans in prevention of menstrual migraine: a systematic review with meta-analysis.

Authors:  Yong Hu; Xiaofei Guan; Lin Fan; Lingjing Jin
Journal:  J Headache Pain       Date:  2013-01-30       Impact factor: 7.277

10.  Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.

Authors:  Elimor Brand-Schieber; Sagar Munjal; Rajesh Kumar; Anthony D Andre; Will Valladao; Margarita Ramirez
Journal:  Med Devices (Auckl)       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.